A Randomized Phase 3 Trial of Palliative Radiation Therapy Versus Concurrent Chemotherapy and Palliative Radiation Therapy in Patients With Good Performance Status, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer With Symptoms Due to Intrathoracic Disease Who Are Not Suitable for Radical Chemo-Radiation Therapy: Results of the Trans-Tasman Radiation Oncology Group 11.03 Trial-Reference-Cited by-同舟云学术

A Randomized Phase 3 Trial of Palliative Radiation Therapy Versus Concurrent Chemotherapy and Palliative Radiation Therapy in Patients With Good Performance Status, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer With Symptoms Due to Intrathoracic Disease Who Are Not Suitable for Radical Chemo-Radiation Therapy: Results of the Trans-Tasman Radiation Oncology Group 11.03 Trial

Published:2020-11 Issue: Volume: Page:
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Lehman Margot,Bernard Anne,See Adrienne,King Madeleine,Michael Michael

Funder

Cancer Australia

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference27 articles.

1. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC;Antonia;N Engl J Med,2018

2. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC: Update from PACIFIC;Antonia;J Thorac Oncol,2020

3. Reasons for palliative treatments in stage III non-small cell lung cancer: What contribution is made by time-dependent changes in tumour or patient status?;Robinson;Curr Oncol,2015

4. Stage III non-small cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment;Al-Shamsi;Clin Lung Cancer,2014

5. Palliative radiation therapy practice in patients with metastatic non-small cell lung cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study;Chen;J Clin Oncol,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations;BMC Cancer;2022-09-24

2. Use and Reporting of Patient-Reported Outcomes in Trials of Palliative Radiotherapy;JAMA Network Open;2022-09-22

3. Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5-Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis and Systematic Review;Journal of Oncology;2022-07-16